1887

Abstract

The 3a protein of severe acute respiratory syndrome (SARS)-associated coronavirus is expressed and transported to the plasma membrane in tissue cells of infected patients. Its short N-terminal ectodomain was found to elicit strong humoral responses in half of the patients who had recovered from SARS. The ectodomain-specific antibodies from the convalescent-phase plasma readily recognized and induced destruction of 3a-expressing cells in the presence of the human complement system, demonstrating their potential ability to provide immune protection by recognizing and eliminating SARS coronavirus-infected cells that express the target protein. In addition, when coupled to a carrier protein, the ectodomain peptide elicited 3a-specific antibodies in mice and rabbit at high titres. These results showed that the N terminus of the 3a protein is highly immunogenic and elicits potentially protective humoral responses in infected patients. Therefore, the short extracellular domain may be a valuable immunogen in the development of a vaccine for infectious SARS.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81078-0
2006-02-01
2019-11-12
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/2/369.html?itemId=/content/journal/jgv/10.1099/vir.0.81078-0&mimeType=html&fmt=ahah

References

  1. Bisht, H., Roberts, A., Vogel, L., Bukreyev, A., Collins, P. L., Murphy, B. R., Subbarao, K. & Moss, B. ( 2004; ). Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci U S A 101, 6641–6646.[CrossRef]
    [Google Scholar]
  2. Buchholz, U. J., Bukreyev, A., Yang, L., Lamirande, E. W., Murphy, B. R., Subbarao, K. & Collins, P. L. ( 2004; ). Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proc Natl Acad Sci U S A 101, 9804–9809.[CrossRef]
    [Google Scholar]
  3. Chang, M.-S., Lu, Y.-T., Ho, S.-T. & 11 other authors ( 2004; ). Antibody detection of SARS-CoV spike and nucleocapsid protein. Biochem Biophys Res Comm 314, 931–936.[CrossRef]
    [Google Scholar]
  4. Chen, Z., Pei, D., Jiang, L. & 11 other authors ( 2004; ). Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein. Clin Chem 50, 988–995.[CrossRef]
    [Google Scholar]
  5. Chinese SARS Molecular Epidemiology Consortium ( 2004; ). Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 303, 1666–1669.[CrossRef]
    [Google Scholar]
  6. Drosten, C., Günther, S., Preiser, W. & 23 other authors ( 2003; ). Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348, 1967–1976.[CrossRef]
    [Google Scholar]
  7. Gao, W., Tamin, A., Soloff, A., D'Aiuto, L., Nwanegbo, E., Robbins, P. D., Bellini, W. J., Barratt-Boyes, S. & Gambotto, A. ( 2003; ). Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 362, 1895–1896.[CrossRef]
    [Google Scholar]
  8. Guo, J.-P., Petric, M., Campbell, W. & McGeer, P. L. ( 2004; ). SARS corona virus peptides recognized by antibodies in the sera of convalescent cases. Virology 324, 251–256.[CrossRef]
    [Google Scholar]
  9. He, Y., Zhou, Y., Wu, H., Luo, B., Chen, J., Li, W. & Jiang, S. ( 2004; ). Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines. J Immunol 173, 4050–4057.[CrossRef]
    [Google Scholar]
  10. Ito, N., Mossel, E. C., Narayanan, K., Popov, V. L., Huang, C., Inoue, T., Peters, C. J. & Makino, S. ( 2005; ). Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein. J Virol 79, 3182–3186.[CrossRef]
    [Google Scholar]
  11. Johnston, R. E. ( 2004; ). A candidate vaccine for severe acute respiratory syndrome. N Engl J Med 351, 827–828.[CrossRef]
    [Google Scholar]
  12. Ksiazek, T. G., Erdman, D., Goldsmith, C. S. & 24 other authors ( 2003; ). A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348, 1953–1966.[CrossRef]
    [Google Scholar]
  13. Leung, D. T. M., Tam, F. C. H., Ma, C. H., Chan, P. K. S., Cheung, J. L. K., Niu, H., Tam, J. S. L. & Lim, P. L. ( 2004; ). Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J Infect Dis 190, 379–386.[CrossRef]
    [Google Scholar]
  14. Liu, X., Shi, Y., Li, P., Li, L., Yi, Y., Ma, Q. & Cao, C. ( 2004; ). Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients. Clin Diagn Lab Immunol 11, 227–228.
    [Google Scholar]
  15. Peiris, J. S. M., Lai, S. T., Poon, L. L. M. & 14 other authors ( 2003; ). Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319–1325.[CrossRef]
    [Google Scholar]
  16. Poutanen, S. M., Low, D. E., Henry, B. & 19 other authors ( 2003; ). Identification of severe acute respiratory syndrome in Canada. N Engl J Med 348, 1995–2005.[CrossRef]
    [Google Scholar]
  17. Rottier, P. J. M. ( 1995; ). The coronavirus membrane glycoprotein. In The Coronaviridae, pp. 115–139. Edited by S. G. Siddell. New York: Plenum.
  18. Ruan, Y., Wei, C. L., Ee, L. A. & 17 other authors ( 2003; ). Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet 361, 1779–1785.[CrossRef]
    [Google Scholar]
  19. Shi, Y., Wan, Z., Li, L., Li, P., Li, C., Ma, Q. & Cao, C. ( 2004; ). Antibody responses against SARS-coronavirus and its nucleocapsid in SARS patients. J Clin Virol 31, 66–68.[CrossRef]
    [Google Scholar]
  20. Siddell, S. G. ( 1995; ). The small-membrane protein. In The Coronaviridae, pp. 181–189. Edited by S. G. Siddell. New York: Plenum.
  21. Subbarao, K., McAuliffe, J., Vogel, L. & 7 other authors ( 2004; ). Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice. J Virol 78, 3572–3577.[CrossRef]
    [Google Scholar]
  22. Tan, Y.-J., Goh, P.-Y., Fielding, B. C. & 9 other authors ( 2004a; ). Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clin Diagn Lab Immunol 11, 362–371.
    [Google Scholar]
  23. Tan, Y.-J., Teng, E., Shen, S. & 7 other authors ( 2004b; ). A novel severe acute respiratory syndrome coronavirus protein, U274, is transported to the cell surface and undergoes endocytosis. J Virol 78, 6723–6734.[CrossRef]
    [Google Scholar]
  24. Wang, J., Wen, J., Li, J. & 30 other authors ( 2003; ). Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus. Clin Chem 49, 1989–1996.[CrossRef]
    [Google Scholar]
  25. Yang, Z.-Y., Kong, W.-P., Huang, Y., Roberts, A., Murphy, B. R., Subbarao, K. & Nabel, G. J. ( 2004; ). A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice. Nature 428, 561–564.[CrossRef]
    [Google Scholar]
  26. Yang, Z.-Y., Werner, H. C., Kong, W.-P., Leung, K., Traggiai, E., Lanzavecchia, A. & Nabel, G. J. ( 2005; ). Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc Natl Acad Sci U S A 102, 797–781.[CrossRef]
    [Google Scholar]
  27. Yeh, S.-H., Wang, H.-Y., Tsai, C.-Y. & 8 other authors ( 2004; ). Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution. Proc Natl Acad Sci U S A 101, 2542–2547.[CrossRef]
    [Google Scholar]
  28. Yu, C.-J., Chen, Y.-C., Hsiao, C.-H. & 9 other authors ( 2004; ). Identification of a novel protein 3a from severe acute respiratory syndrome coronavirus. FEBS Lett 565, 111–116.[CrossRef]
    [Google Scholar]
  29. Zeng, R., Yang, R.-F., Shi, M.-D. & 31 other authors ( 2004; ). Characterization of the 3a protein of SARS-associated coronavirus in infected Vero E6 cells and SARS patients. J Mol Biol 341, 271–279.[CrossRef]
    [Google Scholar]
  30. Zhao, P., Ke, J.-S., Qin, Z.-L., Ren, H., Zhao, L.-J., Yu, J. G., Gao, J., Zhu, S.-Y. & Qi, Z.-T. ( 2004; ). DNA vaccine of SARS-Cov S gene induces antibody response in mice. Acta Biochim Biophys Sin 36, 37–41.[CrossRef]
    [Google Scholar]
  31. Zhong, X., Yang, H., Guo, Z.-F. & 13 other authors ( 2005; ). B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein. J Virol 79, 3401–3408.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81078-0
Loading
/content/journal/jgv/10.1099/vir.0.81078-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error